IMBCR is dedicated to advance the treatment of myeloma by connecting possibility through scientific innovation leading to personalized and continuous optimized patient care.
NT-I7 Enhances CAR T-Cell Efficacy in DLBCL
Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd
Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS
Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer